Navigation Links
Amgen Announces Webcast of 2008 Third Quarter Financial Results
Date:10/20/2008

THOUSAND OAKS, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that it plans to report its third quarter financial results on Wednesday, Oct. 22, 2008 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 1:30 p.m. Pacific Time. Participating in the call from Amgen will be Kevin Sharer, chairman and CEO, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The conference call, including the question and answer session, is expected to last approximately one hour.

The webcast of the conference, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's Web site, http://www.amgen.com, under Investors. Information regarding presentation times, webcast availability, and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay 72 hours after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines,
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
2. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
3. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
4. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
5. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
6. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , SAN FRANCISCO, Dec. 3 /PRNewswire-FirstCall... biotechnology company focused on the development ...nd metabolic disease, today announced that it has ...G-PET clinical trial of VIA-2291. ,, The FDG-P...at five sites in the US and Canada including Massa...
(Date:12/3/2009)... , TUSTIN, Calif., Dec. 3 /PRNewswire-First... PPHM ) today announced that it will release its f...year 2010 on December 10, 2009 at 7:00 a.m. EST an...ss the results at 11:30 a.m. EST on the same day. ...inancial results for the second quarter ended Octo...
(Date:12/3/2009)... , HOPKINTON, Mass., Dec. 3 /PRNewswire-First...P ), a leading provider of tools and services for ...ntroduced Living Image 4.0 software for IVIS®...ives the more than 800 Caliper IVIS systems curren...age 4.0 features advanced spectral unmixing tools ...
(Date:12/2/2009)... , COLUMBIA, Md., Dec. 2 /PRNewswire-FirstCal...K ) announced today that it intends to release the...9 on December 16, 2009, at approximately 4:00 p.m....5 p.m. ET Martek will conduct a conference call to...sted parties may listen to the call live via webca...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2
... editorial titled, "End tax moratorium on Interne...n State Journal (08/07/03). Wisconsin is only one ...distribution and growing industry. The notion of p...es is just plain bad business. We need to encourag...dustry in Wisconsin. From tourism and manufacturin...
...consin , ,MILWAUKEE, WI- Baird Venture Partners ... fund raising that increases the value their fund ... sciences, healthcare and business service with a ...the Midwest. Milwaukees Baird Venture Partners was...tment Board (SWIB) to expand the venture capital ...
...rviewed two University of Wisconsin-Madison resear... how the principles behind learning a game can be ... James Gee. , , James Gee, Ph.D. , is a professor ...cation at UW-Madison. He is the author of What Vid...acy. Dr. Gee received his Ph.D in linguistics from...
Other Biology Technology:Is Wisconsin a Technology Leader or Laggard? 2Milwaukee Company Raises $90 million VC Fund for Midwest Projects 2Milwaukee Company Raises $90 million VC Fund for Midwest Projects 3The Learning Game - Researchers Study Video Gaming Principles that Apply to Education 2The Learning Game - Researchers Study Video Gaming Principles that Apply to Education 3The Learning Game - Researchers Study Video Gaming Principles that Apply to Education 4The Learning Game - Researchers Study Video Gaming Principles that Apply to Education 5The Learning Game - Researchers Study Video Gaming Principles that Apply to Education 6
(Date:12/4/2009)...om the Royal Botanic Gardens, Kew and the Natural ...in plants is far more widespread than previously t...etunias at least part way to being "meat eaters"....c, Darwin and modern insights into vegetable carni... Botanical Journal of the Linnean Society . , Ca...
(Date:12/3/2009)...ALL, N.J., Dec. 3 BIO-ke...a leader in wireless public safety and finger-base...at a majority of its shareholders at a Special Sha...he company,s Law Enforcement Division to Interact9...were cast in favor and 1.2% were opposed. ,, (L...
(Date:12/3/2009)...his message: , , Preliminary Press Conference...ia Academy of Sciences museum, Attention PIOs: S...iday dinner registration deadline 10 December, ... Registration Form pre-registration deadline THIS ...ortant information regarding visas for internation...
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Reportlinker Adds Nanomedicine Report 13899 1Reportlinker Adds Nanomedicine Report 13899 2Reportlinker Adds Nanomedicine Report 13899 3Reportlinker Adds Nanomedicine Report 13899 4Reportlinker Adds Nanomedicine Report 13899 5Reportlinker Adds Nanomedicine Report 13899 6Reportlinker Adds Nanomedicine Report 13899 7Reportlinker Adds Nanomedicine Report 13899 8Reportlinker Adds Nanomedicine Report 13899 9Reportlinker Adds Nanomedicine Report 13899 10Reportlinker Adds Nanomedicine Report 13899 11Video 3A Eat Tastefully Campaign 3A Diet Coke Renowned Chef Pop Up Kitchen Reveal Secrets to Great Taste Living Well 56387 1Video 3A Eat Tastefully Campaign 3A Diet Coke Renowned Chef Pop Up Kitchen Reveal Secrets to Great Taste Living Well 56387 2Video 3A Eat Tastefully Campaign 3A Diet Coke Renowned Chef Pop Up Kitchen Reveal Secrets to Great Taste Living Well 56387 3Video 3A Eat Tastefully Campaign 3A Diet Coke Renowned Chef Pop Up Kitchen Reveal Secrets to Great Taste Living Well 56387 4Inspiring New Online Destination From Bayer Diabetes Care 13896 1Inspiring New Online Destination From Bayer Diabetes Care 13896 2Inspiring New Online Destination From Bayer Diabetes Care 13896 3
...: Adding capecitabine, a drug that inhibits DNA s... docetaxel, in patients with early breast cancer, ...efficacy of treatment, a German scientist told the...day (Thursday 17 April). Previously, such a combi... disease, where the cancer has spread to other par...
...pathogen responsible for Sudden Oak Death first go...ry in Santa Cruz and at Mt. Tamalpais in Marin Cou...ns of oaks and tanoaks along the Pacific Coast, ac...niversity of California, Berkeley. It provides, fo...olded in this state. , "In this paper, we actuall...
... Some primates have evolved big brains because the...longer, an advantage that outweighs the demands of...reaching adulthood, anthropologists from Duke Univ... in a new study. , The four investigators compare...t primate species, ranging from humans living free...
Other Biology News:New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients 2Sudden Oak Death pathogen is evolving, says new study that reconstructs the epidemic 2Sudden Oak Death pathogen is evolving, says new study that reconstructs the epidemic 3Sudden Oak Death pathogen is evolving, says new study that reconstructs the epidemic 4Slowly-developing primates definitely not dim-witted 2Slowly-developing primates definitely not dim-witted 3
Cathepsin L Fluorometric (cresyl violet) Assay Kit, Magic Red from AbD Serotec
Xpression Primer from PREMIER Biosoft International
Feline IL-12 / IL-23 p40, Unconjugated from R&D Systems
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
Biology Products: